The material on this website is provided for informational purposes only and is not medical advice
is convening a meeting of PCAC to consider changing the classification of seven popular peptides, thus allowing them to be compounded and sold by prescription
Because each peptide has an independently published research base addressing a different stage of the tissue-repair cascade vascularization, cell migration, structural protein synthesis, and inflammatory resolution combination research has explored whether administering them together produces a more complete repair-signaling environment than any single peptide alone, an approach frequently referenced in comprehensive tissue-recovery and dermatological research protocols
Most of the data they did find came from studies in animals, including rats, and not humans
The FDA plans to consult the Pharmacy Compounding Advisory Committee about BPC-157 on July 23, 2026, so this could change soon
Some suppliers label it one way, others label it differently